IL28B POLYMORPHISM AND KINETICS OF ANTIVIRAL ACTIVITY FOR ANA598 IN COMBINATION WITH PEGYLATED INTERFERON alpha 2A PLUS RIBAVIRIN IN TREATMENT-NAiVE GENOTYPE-1 CHRONIC HCV PATIENTS
Publication
, Conference
Muir, AJ; Lawitz, E; Rodriguez-Torres, M; Rustgi, VK; Hassanein, T; Appleman, JR; Crowley, CA; Freddo, JL; McHutchison, JG
Published in: HEPATOLOGY
October 1, 2010
Duke Scholars
Published In
HEPATOLOGY
ISSN
0270-9139
Publication Date
October 1, 2010
Volume
52
Issue
4
Start / End Page
1200A / 1200A
Location
Boston, MA
Publisher
WILEY-BLACKWELL
Conference Name
61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Muir, A. J., Lawitz, E., Rodriguez-Torres, M., Rustgi, V. K., Hassanein, T., Appleman, J. R., … McHutchison, J. G. (2010). IL28B POLYMORPHISM AND KINETICS OF ANTIVIRAL ACTIVITY FOR ANA598 IN COMBINATION WITH PEGYLATED INTERFERON alpha 2A PLUS RIBAVIRIN IN TREATMENT-NAiVE GENOTYPE-1 CHRONIC HCV PATIENTS. In HEPATOLOGY (Vol. 52, pp. 1200A-1200A). Boston, MA: WILEY-BLACKWELL.
Muir, Andrew J., Eric Lawitz, Maribel Rodriguez-Torres, Vinod K. Rustgi, Tarek Hassanein, James R. Appleman, Constance A. Crowley, James L. Freddo, and John G. McHutchison. “IL28B POLYMORPHISM AND KINETICS OF ANTIVIRAL ACTIVITY FOR ANA598 IN COMBINATION WITH PEGYLATED INTERFERON alpha 2A PLUS RIBAVIRIN IN TREATMENT-NAiVE GENOTYPE-1 CHRONIC HCV PATIENTS.” In HEPATOLOGY, 52:1200A-1200A. WILEY-BLACKWELL, 2010.
Muir AJ, Lawitz E, Rodriguez-Torres M, Rustgi VK, Hassanein T, Appleman JR, et al. IL28B POLYMORPHISM AND KINETICS OF ANTIVIRAL ACTIVITY FOR ANA598 IN COMBINATION WITH PEGYLATED INTERFERON alpha 2A PLUS RIBAVIRIN IN TREATMENT-NAiVE GENOTYPE-1 CHRONIC HCV PATIENTS. In: HEPATOLOGY. WILEY-BLACKWELL; 2010. p. 1200A-1200A.
Muir, Andrew J., et al. “IL28B POLYMORPHISM AND KINETICS OF ANTIVIRAL ACTIVITY FOR ANA598 IN COMBINATION WITH PEGYLATED INTERFERON alpha 2A PLUS RIBAVIRIN IN TREATMENT-NAiVE GENOTYPE-1 CHRONIC HCV PATIENTS.” HEPATOLOGY, vol. 52, no. 4, WILEY-BLACKWELL, 2010, pp. 1200A-1200A.
Muir AJ, Lawitz E, Rodriguez-Torres M, Rustgi VK, Hassanein T, Appleman JR, Crowley CA, Freddo JL, McHutchison JG. IL28B POLYMORPHISM AND KINETICS OF ANTIVIRAL ACTIVITY FOR ANA598 IN COMBINATION WITH PEGYLATED INTERFERON alpha 2A PLUS RIBAVIRIN IN TREATMENT-NAiVE GENOTYPE-1 CHRONIC HCV PATIENTS. HEPATOLOGY. WILEY-BLACKWELL; 2010. p. 1200A-1200A.
Published In
HEPATOLOGY
ISSN
0270-9139
Publication Date
October 1, 2010
Volume
52
Issue
4
Start / End Page
1200A / 1200A
Location
Boston, MA
Publisher
WILEY-BLACKWELL
Conference Name
61st Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases
Related Subject Headings
- Gastroenterology & Hepatology
- 3204 Immunology
- 3202 Clinical sciences
- 1107 Immunology
- 1103 Clinical Sciences
- 1101 Medical Biochemistry and Metabolomics